Financhill
Back

Biote 10K Form

Sell
18

BTMD
Biote

Last Price:
5.11
Seasonality Move:
-12.82%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive BTMD News And Ratings

See the #1 stock for the next 7 days that we like better than BTMD

BTMD Financial Statistics

Sales & Book Value

Annual Sales: $185.36M
Cash Flow: $7.1M
Price / Cash Flow: 8.9
Annual Sales: $-4.62
Price / Book: 0

Profitability

EPS (TTM): 0.17000
Net Income (TTM): $6.87M
Gross Margin: $127.48M
Return on Equity: 0%
Return on Assets: 4.93%

Biote Earnings Forecast

Key Biote Financial Ratios

  • The Gross Profit Margin over the past 5 years for BTMD is 68.78%.
  • The Selling, General & Administrative Expenses for BTMD have been equal to 53.32% of Gross Profit Margin.
  • The Interest Expense is 191.89% of Operating Income.
  • The Net Earning history of BTMD is 1.79% of Total Revenues.
  • Per Share Earnings over the last 5 years have been positive in 3 years.

Biote Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: BTMD
Website: biote.com

Debt

Debt-to-Equity Ratio: -0.84
Current Ratio: 1.34
Quick Ratio: 0.76

Price-to-Earnings

Trailing P/E Ratio: 39.27
Forward P/E Ratio: 5.43

BTMD Technical Analysis vs Fundamental Analysis

Sell
18
Biote (BTMD) is a Sell

Is Biote a Buy or a Sell?

  • Biote stock is rated a Sell
    The current Biote [BTMD] share price is $5.11. The Score for BTMD is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.